Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit of immunotherapy drugs. The biotech startup will occupy the 11th floor of the Alexandria’s new life science tower at 1150 Eastlake Ave. E.
“We’re very excited about 1150,” said CEO John Mulligan. “It’s beautiful, great views. It’ll be a really fun space.”
Mulligan said Bonum discovered the vacancy during the biotech downturn in 2022. The Alexandria building is in an area of Seattle that’s home to multiple biotech startups and life science research organizations, such as Fred Hutchinson Cancer Research and The Allen Institute.